The Latest Breaking News from Inari Medical

Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.

Inari Medical Inc's (NASDAQ:NARI) Q1 revenue was $86.8 million, up 4% sequentially and 51% Y/Y, beating the consensus of $83.61 million. The increase over the prior year was driven by continued U.S. commercial expansion and new product introductions. The gross margin was 88.5% compared to 91.9% a year ago, modestly lower primarily…

Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inari Medical will report an earnings per share (EPS) of $-0.09.

Inari Medical Inc's (NASDAQ: NARI)